Stoke Therapeutics, Inc. · NASDAQ:STOK
Baker Bros. Advisors LP reported a 5.80% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Baker Bros. Advisors LP reported a 5.80% stake in Stoke Therapeutics, Inc., 3,336,697 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 5.80%
- Shares
- 3,336,697
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baker Bros. Advisors LP | 5.80% | 3,336,697 |
| Baker Bros. Advisors (GP) LLC | 5.80% | 3,336,697 |
| Julian C. Baker | 5.80% | 3,336,697 |
| Felix J. Baker | 5.80% | 3,336,697 |